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Effects of unoprostone isopropyl (unoprostone), a prostaglandin metabolite analog; latanoprost, a PGF2α analog; and PGF2α were examined in
HCN-1A cells, a model system for studies of large conductance Ca2+ activated K+(BK) channel activator-based neuroprotective agents.
Unoprostone and latanoprost, both used as anti-glaucoma agents, have been suggested to act through FP receptors and have neuroprotective
effects. Ion channel activation, plasma membrane polarization, [Ca2+]i changes and protection against long-term irreversible glutamate-induced
[Ca2+]i increases were studied. Unoprostone activated iberiotoxin (IbTX)-sensitive BK channels in HCN-1A cells with an EC50 of 0.6±0.2 nM
and had no effect on Cl− currents. Unoprostone caused IbTX-sensitive plasma membrane hyperpolarization that was insensitive to AL8810, an FP
receptor antagonist. In contrast, latanoprost and PGF2α activated a Cl
− current sensitive to [Ca2+]i chelation, tamoxifen and AL8810, and caused
IbTX-insensitive, AL8810-sensitive membrane depolarization consistent with FP receptor-mediated Ca2+ signaling Cl− current activation.
Latanoprost and PGF2α, but not unoprostone, increased [Ca
2+]i. Unoprostone, PGF2α only partially, but not latanoprost protected HCN-1A cells
against glutamate-induced Ca2+ deregulation. These findings show that unoprostone has a distinctly different mechanism of action from
latanoprost and PGF2α. Whether unoprostone affects the BK channel directly or an unidentified signaling mechanism has not been determined.
© 2007 Elsevier B.V. All rights reserved.Keywords: HCN-1A; Latanoprost; PGF2α; IbTX; Neuroprotection; Glaucoma1. Introduction
The goal of this study was to determine whether unoprostone
exhibited properties consistent with neuroprotective agents,
including protection against neuroexcitatory agent-induced
increases in intracellular [Ca2+]i and activation of Ca
2+- and
voltage-activated K+ channels (maxi K+ or BK channels). These
studies are relevant to the outcomes of unoprostone use in
glaucoma therapy in protecting against vision loss. Primary
open-angle glaucoma (POAG) is a primary cause of blindness
and ocular hypertensive medication delays or prevents the onset
of POAG [1]. Unoprostone causes a reduction in intraocular
pressure (IOP) [2]. It has been shown that unoprostone has
direct effects on the trabecular network thereby lowering IOP by
maintaining aqueous outflow reduced by endothelin-1 (ET-1)
[3]. These effects were shown to arise from preventing ET-1-
induced contraction of the trabecular meshwork by preventing⁎ Corresponding author.
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doi:10.1016/j.bbamem.2006.12.015ET-1 induced [Ca2+]i changes without affecting basal [Ca
2+]i
levels and activation of large conductance Ca2+ activated (BK)
channels [3]. Effects of unoprostone on Ca2+ entry pathways
including L-type Ca2+ channels and Ca2+ release activated Ca2+
channels have been shown [4–6].
However, it is accepted that IOP reduction alone is not
sufficient to protect against vision loss [7–10]. Rather, the loss
of visual field due to glaucoma is directly associated with retinal
ganglion cell death [11]. Several clinical studies suggest that
unoprostone is neuroprotective [12–16]. In vitro studies have
shown that unoprostone prevented apoptosis caused by serum
deprivation [17] or glutamate in retinal progenitor cells [11],
and protected against light induced photoreceptor damage in
intact eyes [18]. A framework for understanding the neuropro-
tective effects of unoprostone has been put forward [2]. In this
model, neuroexcitatory agents cause Ca2+ dysregulation and
unoprostone prevents these effects by activating BK channels
and preventing Ca2+ dysregulation that ultimately leads to
apoptosis. Glutamate can cause neuronal cell delayed Ca2+
deregulation (DCD) [19,20].
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express ibertiotoxin (IbTX) sensitive BK channels [21–25].
They contain BK channels in a natural milieau and they are
responsive to glutamate, but they do not readily allow
determination of whether unoprostone directly or indirectly
activates the BK channel. Single channel studies would be
required for this.
Unoprostone has been suggested to act through the FP
receptor [26–28] like PGF2α [27] and latanoprost [27–29].
These agents bind to the FP receptor [28] and cause [Ca2+]i
mobilization [26,27] and stimulate phosphoinositide hydrolysis
[27]. The EC50 for activation of BK channels by unoprostone
was approximately 0.6 nM, and the other effects of unoprostone
were evident over the range 1–100 nM. These concentrations
are well below the reported EC50 values for FP receptor binding
(5.9 μM) [2] and Ca2+ mobilization (approximately 1 μM) [26]
by unoprostone. The highest concentrations achieved in
treatment with unoprostone was approximately 100 nM [30],
also well below the EC50 for FP receptor occupation or
functional effects such as Ca2+ mobilization [26–28]. There is
one report that unoprostone does not act as an FP receptor
agonist [31]. The basis for this controversy may reside in the
very high EC50 of unoprostone for occupation of FP receptors
[28], and PI turnover [27] and the rapid transient unoprostone-
mediated Ca2+ mobilization compared to other agents [26,27].
The reported findings suggest that unoprostone will activate
BK channels and exhibit membrane hyperpolarization [22–
25]. In contrast, PGF2α or latanoprost occupation of FP
receptors would activate Ca2+-activated Cl− currents through
mobilization of [Ca2+]i resulting in depolarization [26,27,32–
35]. This depolarization should be blocked by tamoxifen, an
anti-estrogen, which also inhibits Ca2+-activated Cl− channels
[35] and would be sensitive to AL8810, an FP receptor
antagonist [27]. Effects on Ca2+ homeostasis [26–28,31] could
be the key to understanding the paradox of unoprostone being
effective in glaucoma therapy despite being much less effective
than PGF2α analogs on FP receptor signaling [26–28,31], and
might shed light on possible neuroprotective effects of
unoprostone [8–11,17,18].
Whole cell patch clamp [36] of HCN-1A cells was used to
measure K+ and Cl− currents. Bis-(1,3-dibutylbarbituric acid)
trimethine oxonol (DiBAC4(3)), a potential sensitive dye, was
used for membrane potential studies [37–40]. The acetoxy-
methyl ester of indo 1 (indo-1/AM) [41,42] was used to measure
[Ca2+]i.
2. Materials and methods
2.1. Materials
Hank's balanced salt solution (HBSS) with and without phenol red, with and
without Ca2+ was from Invitrogen (Carlsbad, California). Dulbecco's modified
Eagle's medium (DMEM), fetal bovine serum (FBS) and human cortical
neuronal cells (HCN-1A cells) were from ATCC (Manassas, VA). Valinomycin,
bis-(1,3-diethylthiobarbituric acid) trimethine oxonol (DiBAC4(3)), the acetox-
ymethyl ester (AM) of indo-1 (indo-1/AM) and of BAPTA (BAPTA/AM) were
from Molecular Probes (Eugene, OR). Latanoprost, PGF2α and unoprostone
[(isopropyl(+)-(z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl) cyclopen-
tyl]-5-heptenoate)] were from R-Tech Ueno, Ltd. (Sanda, Japan) as frozenaliquots of 2 mM solutions in 100% DMSO. DMSO, also from R-Tech Ueno,
Ltd. was used to dilute the compounds. IbTX was from Tocris Cookson
(Ellisville, MO); tamoxifen-4-hydroxy was from Calbiochem (La Jolla, CA).
Tetrodotoxin (TTX), AL8810, glutamate, Na2ATP and ionomycin were from
Sigma-Aldrich (St. Louis, MO). 2 mM unoprostone, latanoprost and PGF2α
were diluted with DMSO to give a final DMSO concentration of 0.1%. 0.1%
DMSO controls were always carried out. IbTX and TTX were dissolved in
water; AL8810, tamoxifen and BAPTA/AM were dissolved in DMSO and indo-
1/AM was dissolved in ethanol.
2.2. Cell culture
HCN-1A cells were grown in DMEM medium with 10% FBS to 85–90%
confluence on autoclaved 9x22 mm glass cover slips (Bellco Co. NJ). After 48 h
in culture, these cells were used for experiments for 1 week and then fresh cells
were plated. For patch clamp HCN-1A cells were seeded in 35 mm plastic petri
dishes.
2.3. Patch clamp measurement of whole cell K+ and Cl− currents
Patch-clamp and analytical methods were as described previously [36]. K+,
currents were elicited by voltage clamp pulses (200 ms duration) between −70
and +130 mV in 20 mV steps from a beginning holding potential of −70 mV.
Cl− currents were elicited by voltage-clamp pulses (200 ms duration) between
+40 and −140 mV in 20 mV increments from a beginning holding potential of
−30 mV. Currents were averaged over a 50-ms time course starting at 50 ms and
ending at 100 ms. For measurement of K+ currents, the external solution
contained (mM): 135 Na-methanesulfonate, 5 K-methanesulphonate, 2 MgCl2,
5 glucose, and 10 HEPES pH 7.35. Tetrodotoxin (100 nM) was present to inhibit
Na+ channel currents. The pipette solution contained (mM): 140 K-
methanesulphonate 0.1 CaCl2, 2 MgCl2, 0.1 Na2-ATP, 0.1 Na2-GTP, 0.145
EGTA and 10 HEPES pH 7.35. These solutions were also used to determine the
resting membrane potential. Free Ca2+ in the pipet was calculated [43] to be
112 nM. For measurements of Cl− currents, the external solution contained
(mM): 150 tetraethyl ammonium Cl−, 1.8 CaCl2, 2 MgCl2, 5 glucose and 10
HEPES pH 7.3. The pipette contained (mM): 150 tetraethyl ammonium Cl−, 1
MgATP (1:1), 2 MgCl2 and 10 HEPES pH 7.3. The resting membrane potential
at 24 °C was determined by current clamp to be −67.3±0. 2 mV (n=5) in the
following solutions. The external solution contained (mM): 135 NaCl. 5.4 KCl,
1.8 CaCl2, 1 MgCl2, 5 glucose and 10 HEPES pH 7.35. The pipette contained
(mM): 140 KCl, 2 MgCl2 and 10 HEPES pH 7.35.
Pipettes were prepared from borosilicate glass and pulled by a two-stage
Narashige puller to produce 1- to 1.5-MΩ resistance. The average cell capacitances
for K+ channel experiments were 57.5±2.9 pF (n=20) and for Cl− channel
experiments was 45.8±3.7 pF (n=3). Data were acquired with an Axopatch CV-
4 headstage, a Digidata 1200 digitizer, and an Axopatch 1D amplifier. The
sampling frequency was 1 kH, filter setting was 1 kH, and seal resistances were
10 gΩ. Data were analyzed using pClamp 6.04 (Axon Instruments, Union City,
CA), Lotus 1-2-3 (IBM, White Plains, NY), and Origin 5 (OriginLab,
Northampton, MA).
2.4. Measurement of plasma membrane potential
HCN-1A cells grown on cover slips were incubated with 100 nM DiBAC4
(3) in HBSS for 5 min in the dark. DiBAC4(3) is a slow response membrane
potential fluorescent probe. To ensure that the dye was at steady state after 5 min,
the scans were taken from the same cover slip at 5 min and at 15 min (n=3
coverslips) after adding DiBAC4(3) and the apparent change was 1.25±
0.26 mV, which was small compared to the changes observed with test
compounds. With test compounds cells were incubated for 3–5 min in the dark.
Coverslips were placed in a stirred cuvette in an ISS K2 fluorometer and the
signal was maximized by positioning the coverslip. Scans of 130 s were
recorded with excitation at 540 nm and emission at 579–580 nm and then
normalized to emission at 560 nm. For calibration, valinomycin (1 μM) was
added to cells with different concentrations of external KCl. All of the
compounds were tested under cell free conditions with 100 nM DiBAC4(3). No
effects were observed at the highest concentrations of agents used here. In
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latanoprost and PGF2α responses. The highest concentration that could be used
was 1 nM, which did not affect responses to latanoprost or PGF2α, while still
blocking unoprostone effects. AL8810 caused no effect in cell free experiments.
It blocked latanoprost and PGF2α depolarization without an effect on
unoprostone-mediated hyperpolarization, but appeared to have a non-specific
effect of causing what appears to be membrane depolarization. Membrane
potential was calculated using the Nernst equation and assuming the resting
membrane potential was −67.3 determined by current clamp (see previous
section) and intracellular K+ was 140 mM [37]. The calibration was performed
with 3 coverslips in each set of experiments. Fig. 1 shows the calibration curve
from 4 sets of calibrations which was linear (correlation coefficient=0.8). The
fluorescence change was 0.08±0.003 units per 100 mV (n=8). Calibrations and
all experiments were carried out at 24 °C. Multiple scans were combined and
normalized to emission at 560 nm using the VINCI package (ISS, Champaign,
IL). HBSS (pH 7.3) contained (in mM): NaCl 137, KCl 5.4, NaHCO3 3.3,
Na2HPO4 0.34, KH2PO4 0.44, MgCl2 0.5, MgSO4 4, CaCl2 1.2, glucose 5.5
(1 mg /ml). In some cases, the media contained 10 μg/ml phenol red. This did
not affect the measurements, therefore data were combined.
2.5. Measurement of intracellular free Ca2+ concentration, [Ca2+]i
HCN-1A cells were incubated at 37 °C with 2.5 mM indo-1/AM in HBSS
for 30 min. Cells were then mounted in the ISS K2 fluorimeter in indo-1/AM-
free HBSS at 22 °C. Scans were typically 190 s. Fluorescence was measured
with excitation at 338 nm and emission at 401 nm (390–410 nm). [Ca2+]i was
calculated according to Grynkiewicz et al. [42] and Rego et al. [43] using the
equation: [Ca2+]i=Kd[(F−Fmin) / (Fmax−F)], where Kd=230 μM for indo-1 at
22 °C. Fmax was measured after addition of 3 μM ionomycin in the presence of
extracellular Ca2+. Fmin was then measured after addition 3 mM of Mn
2+. Fmax
and Fmin were measured at the end of every experiment.
2.6. Statistical analysis
Statistical significance was determined using Students t-test and ANOVA
with Post-Hoc tests as needed. Origin 5 was used to fit the curves. The number
of experiments (n) and P values for statistical significance are indicated on
graphs, in legends and in the text.Fig. 1. Calibration curve for estimation of plasma membrane potential using the
potential sensitive dye, DiBAC4(3). HCN-1A cells were grown to confluence on
glass coverslips and then incubated with 100 nM DiBAC4(3) in HBSS without
KCl in the dark. Scans were recorded with excitation at 540 nm and emission at
579–580 nm for 130 s. Emission was normalized at 560 nm. Emission intensity
was measured after adding 1 μM valinomycin followed by increasing
concentrations of KCl. Membrane potential was estimated using the Nernst
equation, assuming a resting membrane potential of −67.3 mV determined by
current clamp and an intracellular K+ concentration of 140 mM. The
fluorescence change was 0.08±0.003 units per 100 mV (n=11). Data are
plotted as mean±SEM, n=8; correlation coefficient, r=0.8.3. Results
3.1. Effect of unoprostone on K+ currents in HCN-1A cells:
effects of IbTX and [Ca2+]i chelation
The effect of unoprostone on K+ currents in HCN-1A cells
was investigated by whole cell patch clamp. To ensure that the
currents were due to K+, K+ methanesaulfonate was used in the
pipette and Na+ methanesulfonate plus K+ methanesulfonate
and 100 nM tetrodotoxin (to inhibit any Na+ currents) were
present in the bath. Fig. 2 shows (A) representative whole cell
K+ currents and (B)(UC aI )-V curves and (C) mean data for
currents normalized to cell capacitance. HCN-1A cells had a
small control K+ current (22.1±3.5 pA/pF, n=4) that was
significantly (P<0.05) activated by 1 nM unoprostone to 37.5±
3.5 pA/pF (n=4). The unoprostone-stimulated K+ current was
abolished by 100 nM IbTX (P<0.05) to 16.6±5.2 pA/pF
(n=4), indicating that the K+ current is occurring through BK
channels. To examine the effect of varying unoprostone
concentration on K+ currents in HCN-1A cells, one concentra-
tion of unoprostone in 0.1% DMSO was tested and then washed
away with three changes of media prior to addition of the next
concentration. This procedure washed away both unoprostone
and DMSO. 0.1% DMSO had no effect on the currents. Fig. 2D
shows the dose response curve for unoprostone-activated IbTX
sensitive K+ currents. The data were fitted with a modified
Michaelis–Menten hyperbolic plot using Origin 5. The EC50 for
IbTX-sensitive unoprostone activation of BK K+ currents was
0.6±0.2 nM (n=6). Unoprostone thus activated K+ currents
through BK channels that are IbTX-sensitive. There was no
effect of 1 nM latanoprost or 1 nM PGF2α on IbTX-sensitive K
+
currents (n=3), data not shown.
3.2. Effect of latanoprost on Cl− currents in HCN-1A cells:
effects of tamoxifen, [Ca2+]i chelation and AL8810
The effect of latanoprost followed by tamoxifen or the FP
receptor antagonist AL8810 on Cl− currents in HCN-1A cells
was then investigated by whole cell patch clamp (Fig. 3). Fig.
3A shows representative current recordings, I–V curves and
mean data for currents normalized to capacitance. HCN-1A
cells have a low control Cl− current of −21.5±2.3 pA/pF
(n=5) that was significantly activated (P<0.005) to −61.5±
7.8 pA/pF (n=5) by 1 nM latanoprost. Subsequent treatment
with 20 μM tamoxifen significantly inhibited (P<0.05) the
Cl− currents to −28.9±0.7 pA/pF (n=3). As will be shown
later latanoprost caused an increase in [Ca2+]i. The effect of
[Ca2+]i chelation on the latanoprost response was therefore
examined. Fig. 3B shows that [Ca2+]i chelation by incubation
of the cells with 20 μM BAPTA/AM in Ca2+-free medium
[44] for 35 min prior to patching reduced the latanoprost-
activated Cl− current. With BAPTA, control Cl− current was
−35.7±2.3 (n=5) and after 1 nM latanoprost the Cl− current
was −38.4±6.4 (n=5), not significantly different from
control. As shown in Fig. 3C, 5 μM AL8810 abolished
latanoprost activation of Cl− currents, but subsequent
treatment with the Ca2+ ionophore, ionomycin (1 μM), sig-
Fig. 3. Effect of latanoprost on Cl− currents of HCN-1A cells: effects of (A)
tamoxifen, (B) [Ca2+]i chelation and (C) AL8810. Whole cell Cl
− currents were
measured in HCN-1A cells by patch clamp. Representative Cl− currents are
shown on the left. On the right are shown the I–V curves (n=5) in (A), and
summarized normalized Cl− currents (pA/pF). Cl− currents normalized to cell
capacitance (pA/pF) were plotted as mean±SEM. Number of experiments is
indicated in brackets. (A) Cells were treated with 1 nM latanoprost followed by
20 μM tamoxifen. #P<0.005 and **P<0.05 with respect to control and
tamoxifen respectively. (B) Cells were treated with 1 nM latanoprost after
treatment with 20 μM BAPTA/AM to chelate [Ca2+]i. No significant changes
were observed. (C) Cells were treated with 5 μM AL8810, followed by 1 nM
latanoprost and then by 1 μM ionomycin (hatched column). #P<0.005 with
respect to control, AL8810 and AL8810+latanoprost.
Fig. 2. Effect of unoprostone on K+ currents and I–V curves in HCN-1A cells
and effects of IbTX (A, B and C); Effect of varying unoprostone concentration
on K+ currents in HCN-1A cells (D). (A) Whole cell K+ currents were measured
in HCN-1A cells by patch clamp. Representative K+ currents are shown before
and after treatment with 1 nM unoprostone followed by 100 nM IbTX. The I–V
curves (n=4) are shown in (B). (C) Summarized K+ currents normalized to cell
capacitance (pA/pF) are plotted as mean±SEM. Number of experiments (n) is
indicated in brackets. **P<0.05 with respect to control and IbTX. (D) To
examine the effect of varying unoprostone concentration on K+ currents in
HCN-1A cells, one concentration of unoprostone in 0.1% DMSOwas tested and
then washed away with three changes of media prior to addition of the next
concentration. This procedure washed away both unoprostone and DMSO. 0.1%
DMSO had no effect on the currents. Unoprostone concentration is plotted
against the change (Δ) in K+ current normalized to the cell capacitance (pA/pF),
measured by patch clamp at +130 mV holding potential, and expressed as
mean±SEM (n=7). Data were fit with a modified Michaelis–Menton
hyperbolic plot using Origin 5. EC50=0.6±0.2 nM (n=6).
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6.2 pA/pF (n=3). Latanoprost thus activated tamoxifen- and
AL8810-sensitive Cl− currents which were [Ca2+]i-dependent.
3.3. Effect of PGF2α on Cl
− currents in HCN-1A cells: effects
of [Ca2+]i chelation and tamoxifen
The effect of PGF2α on Cl
− currents of HCN-1A cells was
then investigated (Fig. 4). Representative current traces are
shown on the left and on the right are I–V curves in (A) and
Fig. 4. Effect of PGF2α on Cl
− currents of HCN-1A cells (A), effects of [Ca2+]i
chelation (B) and tamoxifen (C). Whole cell Cl− currents were measured in
HCN-1A cells by patch clamp. Representative Cl− currents are shown on the
left. On the right are shown summarized Cl− currents normalized to cell
capacitance (pA/pF) plotted as mean±SEM. In (C) the I–V curves are also
shown (n=3). Number of experiments is indicated in brackets. Cells were
treated with 1 nM PGF2α (A) under normal Ca
2+ conditions, (B) after [Ca2+]i
chelation with 20 μM BAPTA/AM and (C) followed by 20 μM tamoxifen.
#P<0.005 with respect to control and tamoxifen, ##P<0.005 with respect to
without BAPTA in (A).
Fig. 5. Effect of unoprostone on Cl− currents of HCN-1A cells. Whole cell Cl−
currents were measured in HCN-1A cells by patch clamp. Representative Cl−
currents (A) and summarized Cl− currents normalized to cell capacitance (pA/pF)
plotted as mean±SEM (B) are shown. Number of experiments is indicated in
brackets. Cells were treated with 1 nM unoprostone followed by 1 nM PGF2α
under normal Ca2+ conditions. **P<0.05, with respect to control and unoprostone.
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latanoprost, 1 nM PGF2α activated a significant (P<0.005)
Cl− current from −19.0±4.7 pA/pF (n=3) to −79.7±8.2 pA/pF
(n=3) (Fig. 4A). As shown in Fig. 4B, this PGF2α-activated Cl
−
current was significantly reduced (P<0.005) when cell [Ca2+]i
was chelated by incubation in Ca2+-free media and treatment
with 20 μM BAPTA/AM (−28.0±5.5 pA/pF, n=4). The effect
of 20 μM tamoxifen added after PGF2α is shown in Fig. 4C. The
PGF2α-activated Cl
− current (from −12.9±1.5 pA/pF (n=4) to
−64.4±8.4 pA/pF (n=4)) was abolished by 20 μM tamoxifen
(−16.9±3.3 pA/pF (n=4),P<0.005). Thus PGF2α also activated
[Ca2+]i- and tamoxifen-sensitive Cl
− currents.3.4. Effect of unoprostone on Cl− currents in HCN-1A cells
The effect of unoprostone on Cl− currents in HCN-1A cells
was then investigated. Tetraethyl ammonium Cl was used in the
pipette and bath to ensure that the currents measured were due to
Cl−. In contrast to the effects of latanoprost and PGF2α, Fig. 5
shows that 1 nM unoprostone had no effect on Cl− currents:
−27.3±1.0 pA/pF (n=3) control and −29.6±1.3 pA/pF (n=3)
with unoprostone. Subsequent addition of 1 nM PGF2α,
significantly increased (P<0.05) the Cl− current to −75.7±
9.1 pA/pF (n=3). When the experiment was repeated at 1 μM
unoprostone, there was no effect on Cl− currents (n=3), data not
shown. These findings indicate a major difference in the mecha-
nism of action between unoprostone and PGF2α as well as
between unoprostone and latanoprost (compare Figs. 3, 4 and 5).
3.5. Effects of unoprostone, latanoprost and PGF2α on
membrane potential of HCN-1A cells
BK channel activation has been shown to cause membrane
hyperpolarization [23] due to exit of K+. PGF2α is known to
cause membrane depolarization [33] due to exit of Cl−.
Potential sensitive dyes provide a useful way to monitor
membrane potential upon activation of BK channels or when
multiple ion channels might be activated [39,40]. DiBAC4(3)
was used to monitor changes in the membrane potential of
HCN-1A cells after treatment with unoprostone, latanoprost and
PGF2α. Fig. 6 shows that unoprostone caused a dose dependent
hyperpolarization of −31.3±1. 9 mV (n=10) at 100 nM. In
contrast, 100 nM latanoprost caused a depolarization of 61.4±
2.5 mV (n=7) and 100 nM PGF2α caused a depolarization of
40.2 mV±1. 8 mV (n=6).
3.6. Effects of AL8810, an FP receptor antagonist, and IbTX on
membrane potential changes induced by unoprostone,
latanoprost and PGF2α in HCN-1A cells
PGF2α and latanoprost both bind with high affinity to FP
receptors, while unoprostone has a low affinity [28]. The effect
Fig. 6. Effect of unoprostone, latanoprost and PGF2α on changes in membrane
potential of HCN-1A cells. Membrane potential changes were measured using
the fluorescent membrane potential-sensitive dye, DiBAC4(3) after addition of
1, 10 and 100 nM final concentrations of unoprostone, latanoprost or PGF2α.
Change in membrane potential was calculated from the fluorescence change
using the calibration curve shown in Fig. 1. Data are plotted as mean±SEM.
Number of experiments is indicated in brackets. All points with drugs (1, 10 and
100 nM) were significantly different from control P<0.001.
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latanoprost- and PGF2α-induced membrane potential changes in
HCN-1A cells was then investigated. The effect of the BK
channel-specific inhibitor, IbTX was also examined The results
are shown in Fig. 7.
The hyperpolarization induced by 100 nM unoprostone was
not significantly affected by 0.5 μM AL8810 (−31.3±1.9 mV
(n=15) without AL8810 and −25.2±1.5 mV (n=7) with
AL8810). The effect of AL8810 alone is also shown. AL8810
alone caused depolarization (+23.3±2.3, n=19) indicating that
AL8810 had no effect on the unoprostone-induced hyperpolar-
ization, although it does cause an effect consistent with
depolarization on its own. IbTX was used at 1 nM since at
higher concentrations it appeared to alter dye binding. 1 nMFig. 7. Effect of AL8810, an FP receptor antagonist and iberiotoxin (IbTX) on unopro
1A cells. Membrane potential change was measured with DiBAC4(3) after addition
conditions or with pre-treatment with 0.5 μMAL8810. Also shown is the effect of 1 n
are with IbTX. Δmembrane potential was calculated from the fluorescence chan
SEM. Number of experiments is indicated in brackets. *P<0.001 and #P<0.005 wiIbTX alone caused a depolarization of 14.1±1.9 mV (n=4),
suggesting that BK channels play a role in the resting membrane
potential. IbTX significantly reduced unoprostone-induced
hyperpolarization from −31.3±1.3 mV (n=15) to −5.3±
1.8 mV (n=4) P<0.001, demonstrating that unoprostone effects
are mediated through BK channels.
In contrast, 0.5 μM AL8810 caused a large and significant
decrease in the depolarization caused by 100 nM latanoprost
from 62.5±2. 2 mV (n=14) to 30.5±3.6 mV (n=7), P<0.001
and by 100 nM PGF2α from 43.8±4.7 mV (n=10) to 14.5±
1.2 mV (n=7), P<0.001. 1 nM IbTX did not inhibit
depolarization caused by either latanoprost or PGF2α. These
results suggest that Ca2+-activated Cl− channels are involved in
the depolarization caused by latanoprost and PGF2α. Tamoxifen
could not be used here because there are reports that tamoxifen
also interacts with BK channels [45].
3.7. Effects of unoprostone, latanoprost and PGF2α on [Ca
2+]i
The effects of 100 nM unoprostone, latanoprost and PGF2α
on [Ca2+]i were then measured (Fig. 8). HCN-1A cells were
loaded for 30 min with 2. 5 μM indo-1/AM in HBSS, washed in
indo-1/AM-free HBSS and mounted in the fluorimeter. Scans
were taken 60 min after the addition. DMSO alone had no
effect. Basal [Ca2+]i was 58.8±3.5 nM (n=46) in control and
60.9±2. 3 nM (n=5) in DMSO control. Unoprostone caused a
small but significant (P<0.01) decrease in [Ca2+]i from 60.9±
2.3 nM (n=5) to 41.7±3.6 nM (n=5). In contrast, latanoprost
and PGF2α caused large (P<0.001) increases in [Ca
2+]i to
446.1±5.6 nM (n=5) and 428.4±20.5 nM (n=5) respectively.
3.8. Effects of unoprostone, latanoprost and PGF2α,
on glutamate-induced [Ca2+]i deregulation
To investigate the effects of unoprostone, latanoprost and
PGF2α on [Ca
2+]i deregulation by glutamate, [Ca
2+]i wasstone-, latanoprost- and PGF2α-induced changes in membrane potential of HCN-
of 100 nM unoprostone, latanoprost or PGF2α to HCN-1A cells under control
M IbTX on the unoprostone, latanoprost and PGF2α responses. Hatched columns
ge using the calibration curve shown in Fig. 1. Data are plotted as mean±
th respect to control.
Fig. 9. Effect of unoprostone, latanoprost and PGF2α on glutamate-induced
[Ca2+]i deregulation as measured by [Ca
2+]i changes in HCN-1A cells. After
loading HCN-1A cells with 2.5 μM indo-1/AM in HBSS, the cells were
scanned. The cells were then treated with 10 μM glutamate±100 nM
unoprostone, latanoprost or PGF2α or DMSO (vehicle for the drugs) for
60 min. Glutamate was then removed and the cells were incubated with
DMSO or drug alone for a further 30 min and then scanned. Scans were 190 s
[Ca2+]i is plotted as mean±SEM. Number of experiments is indicated in
brackets. 0 time and 90 min controls±DMSO are also shown. *P<0.001 with
respect to ±90 min DMSO control.
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indo-1/AM in HBSS, washed in indo-1/AM-free HBSS and
mounted in the fluorimeter. After scanning (0 time), 10 μM
glutamate±100 nM drug were added, incubated for 1 h and then
scanned again. This was then followed by removal of glutamate
and incubation of the cells with the drugs alone for a further
30 min and then another scan was performed. At the end of each
experiment Fmax was measured after addition of 3 μM
ionomycin and Fmin was measured after addition of 3 mM
Mn2+. [Ca2+]i was calculated and the results are shown in Fig. 9.
Control [Ca2+]i at 0 time was 51.7±3.5 nM (n=31) and at
90 min was 68.3±1.8 nM (n=5). Addition of 10 μM glutamate
for 1 h and incubation in fresh HBSS alone for an additional
30 min caused a large significant (P<0.001) [Ca2+]i increase to
1865.9±83.7 nM (n=5). Since the drugs were dissolved in
DMSO (0.1% final concentration), controls with 0.1% DMSO
were carried out. Control [Ca2+]i with DMSO (vehicle for the
drugs) at 0 time was 60.9±2.3 nM (n=5) and at 90 min was
86.3±5.4 nM (n=5). DMSO added with the glutamate had no
additional effect, with [Ca2+]i at 1918.2±224.1 nM (n=5).
When this experiment was then performed with 100 nM
unoprostone present with glutamate for 60 min, followed by
removal of glutamate but with unoprostone's continued
presence, [Ca2+]i decreased greatly (about 90%) and signifi-
cantly (P<0.001) to 203.9±21.1 nM (n=6) compared to
glutamate/DMSO at 90 min. In contrast, with 100 nM
latanoprost and glutamate [Ca2+]i remained very high at
1646.8±226.5 nM (n=5), not significantly different from
glutamate/DMSO at 90 min, but significantly higher (P<0.001)
than DMSO control without glutamate at 90 min and glutamate
plus unoprostone. With 100 nM PGF2α and glutamate, although
[Ca2+]i was significantly reduced by about 45% compared to
glutamate/DMSO at 90 min (P<0.02), it was still significantly
high at 1065.5±119.2 nM (n=5) compared to control DMSO
90 min (P<0.001) and compared to glutamate plus unoprostoneFig. 8. Effect of unoprostone, latanoprost and PGF2α on [Ca
2+]i in HCN-1A
cells. After loading HCN-1A cells with 2.5 μM indo-1/AM in HBSS, the cells
were scanned. The cells were incubated with DMSO (vehicle for the drugs) or
with 100 nM of the indicated drug for 60 min and then scanned. Scans were
190 s [Ca2+]i is plotted as mean±SEM. Number of experiments is indicated in
brackets. *P<0.001 and ##P<0.01 with respect to DMSO control.(P<0.005). Thus unoprostone almost completely (about 90%)
reversed the glutamate-induced [Ca2+]i increase, while PGF2α
caused only partial reversal (about 45%) and latanoprost caused
no reversal of the glutamate-induced [Ca2+]i increase. Uno-
prostone but not latanoprost reversed, and PGF2α only partially
reversed glutamate-induced [Ca2+]i deregulation in HCN-1A
cells.
4. Discussion
HCN-1A cells are a well established model system to study
BK channels and BK channel activator-based neuroprotective
agents [21–25]. In HCN-1A cells, unoprostone activated an
IbTX-sensitive BK channel-mediated K+ current with an EC50
of 0.6±0.2 nM (n=6). 1 nM unoprostone (and up to 1 μM) had
no effect on Cl− currents. In contrast, latanoprost and PGF2α
activated tamoxifen-sensitive Cl− currents that were sensitive to
[Ca2+]i chelation and AL8810. Long-term (1 h) treatment with
unoprostone slightly reduced [Ca2+]i and caused hyperpolariza-
tion of HCN-1A cell membrane potential that was insensitive to
AL8810, but inhibited by IbTX. In contrast, latanoprost and
PGF2α caused large increases in [Ca
2+]i, and depolarization of
HCN-1A cell membrane potential that was inhibited by
AL8810, but not by IbTX. Irreversible glutamate-induced
DCD was almost completely reversed by unoprostone (90%)
but not by latanoprost and only partially by PGF2α (45%).
When the findings in HCN-1A cells with unoprostone are
compared with findings of other well established neuroprotec-
tive agents including NS-1619 [22,25], BMS 204352 [23,24],
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classified in a similar category, namely a BK channel activator
with neuroprotective effects. These findings suggest a firm basis
for previous suggestions of neuroprotection by unoprostone in
vitro [11,17,18], and in limited clinical trials [12–16].
The equilibrium potential for neurons is such that K+ and Cl−
will exit the cell [33,34,38]. Unoprostone activation of BK
channels was similar to that seen by other agents [22–25]. BK
channel activation led to loss of K+ and hyperpolarization. The
hyperpolarization in the presence of unoprostone suggests that
Cl− currents were not activated as much (or at all) as K+ currents
by unoprostone. Indeed, no activation of Cl− currents was
observed with unoprostone treatment. The Cl− currents were
sensitive to tamoxifen, as expected from studies of cloned
CLCAs, but like other Cl− channel blockers, tamoxifen also has
effects on other Cl− channels [35,46]. Tamoxifen also affects
BK channels [45], so it was not used in studies of BK channel
activation or in membrane potential measurements.
The present studies demonstrate that unoprostone exhibits
fundamentally different effects on ion channels and cellular and
molecular pathways than latanoprost and PGF2α. The primary
mechanism whereby unoprostone exerts its effects is through
BK channel activation. The primary mechanism whereby
latanoprost and PGF2α exert their effects is through FP receptor
occupation, [Ca2+]i increases and activation of Ca
2+-activated
Cl− channels.
The EC50 for activation of BK channels by unoprostone was
approximately 0.6 nM, and the other effects of unoprostone
were evident over the range 1–100 nM. These concentrations
are well below the reported EC50 values for FP receptor binding
(5.9 μM) [29] and Ca2+ mobilization (approximately 1 μM) [26]
by unoprostone. The highest concentrations achieved in
treatment with unoprostone was approximately 100 nM [34],
also well below the EC50 for FP receptor occupation or
functional effects such as Ca2+ mobilization [26–28]. In
contrast, the concentrations of latanoprost achieved in treatment
are similar to the EC50 for PGF2α occupation of FP receptors
and functional effects [28,47]. Thus, while unoprostone might
interact with FP receptors at very high concentrations [26–28],
the effects of unoprostone in the present study occur at
concentrations much lower than those required for significant
occupation of FP receptors, but similar to concentrations
achieved in clinical treatments.
This view was supported by the lack of effect of AL8810 on
membrane hyperpolarization by unoprostone, thus showing that
FP receptor-mediated signaling was not involved in unopros-
tone-mediated membrane hyperpolarization under the condi-
tions of the present studies. In contrast AL8810 inhibited
membrane depolarization by both latanoprost and PGF2α,
preventing FP receptor dependent [Ca2+]i increases [26–28],
thereby preventing activation of Ca2+-activated Cl− currents
[32–34]. This is the likely basis of latanoprost and PGF2α
effects on membrane potential. The reason for the apparent
depolarization by AL8810 alone (without a significant effect on
hyperpolarization by unoprostone) but reduction in depolariza-
tion by both latanoprost and PGF2α is not known. It does not
appear to be due to dye binding in cell free experiments or thelack of effect on unoprostone mediated hyperpolarization. It
does appear to have a non-specific effect in addition to the
specific effect of blocking latanoprost and PGF2α effects.
However the hyperpolarizing effect of unoprostone was likely
due to another mechanism: more direct AL8810-insensitive
activation of IbTX-sensitive BK K+ channels. In fact, IbTX did
inhibit the hyperpolarization caused by unoprostone, but did not
inhibit depolarization by latanoprost and PGF2α.
The present studies show that unoprostone and latanoprost
and PGF2α differ in terms of effects on BK K
+ channels, Cl−
channels, membrane potential and protection against glutamate-
induced DCD. The well-established measurements of FP
receptor-mediated functions also clearly differentiate unopros-
tone from latanoprost based on the low peak mean concentrations
for unoprostone [30] achieved compared to the high EC50 values
for FP receptor-mediated functional effects for unoprostone.
Glutamate has been shown to cause DCD in mammalian
central neurons [19] and retinal ganglion cells [11]. Unopros-
tone, but not latanoprost was shown to reverse DCD in retinal
ganglion cells [11]. The role of glutamate in glaucoma is
controversial [48–50] but similar effects were seen with
endothelin-1- and KCl-induced changes in [Ca2+]i [50]. The
effect of unoprostone on glutamate-induced DCD also differ-
entiates unoprostone from latanoprost and PGF2α. Glutamate-
induced DCD was prevented by unoprostone, but not by
latanoprost and only partially by PGF2α. To the extent that
prevention of DCD predicts cell survival with a glutamate
challenge [11], these findings further suggest that unoprostone
has neuroprotective effects.
The present studies suggest that the BK K+ channel
activation properties of unoprostone are likely responsible for
effects seen in the trabecular meshwork [3] and may provide a
basis for understanding neuroprotective effects seen in limited
clinical trials [12–16] and in vitro studies [11,17,18].
In summary, unoprostone is fundamentally different in its
cellular and molecular effects from PGF2α and latanoprost.
PGF2α and latanoprost bind to FP receptors and cause FP
receptor signaling leading to membrane depolarization. Uno-
prostone does not activate FP receptors at the concentrations
used in the present studies which are relevant to the
concentrations found in clinical pharmacokinetic studies.
Unoprostone rather appears to activate BK K+ channels more
directly causing hyperpolarization and reduced glutamate-
induced DCD. These findings show that unoprostone has a
distinctly different mechanism of action from latanoprost and
PGF2α. Whether unoprostone affects the BK channel directly or
an unidentified signaling mechanism that activates BK channels
remains to be determined.
Acknowledgements
We thank Glenn Doerman for his patient help with the
figures. This study was supported by a grant from Sucampo AG
to John Cuppoletti. John Cuppoletti, Danuta H. Malinowska
and Ryuji Ueno have financial interests in Sucampo AG.
Unoprostone or Rescula™ is manufactured by R.Tech Ueno, a
Sucampo Company.
1091J. Cuppoletti et al. / Biochimica et Biophysica Acta 1768 (2007) 1083–1092References
[1] M.A. Kass, D.K. Heuer, E.J. Higginbotham, C.A. Johnson, J.L. Keltner,
J.P. Miller, R.K. Garrish 2nd, W.R. Wilson, M.O. Gordon, The Ocular
Hypertension Treatment Study: a randomized trial determines that topical
ocular hypotensive medication delays or prevents the onset of primary
open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 701–713 and
829–830.
[2] S. Melamed, Neuroprotective properties of a synthetic docosanoid,
unoprostone isopropyl: clinical benefits in the treatment of glaucoma,
Drugs Exp. Clin. Res. 28 (2002) 63–73.
[3] H. Thieme, F. Stumpff, A. Ottlecz, C.L. Percicot, G.N. Lambrou,
M. Wiederholt, Mechanisms of action of unoprostone on trabecular
meshwork contractility, Invest. Ophthalmol.Vis. Sci. 42 (2001) 3193–3201.
[4] T. Yoshitomi, K. Yamaji, H. Ishikawa, Y. Ohnishi, Vasodilatory
mechanism of unoprostone isopropyl on isolated rabbit ciliary artery,
Curr. Eye Res. 28 (2004) 167–174.
[5] H. Thieme, K. Steinhausen, A. Ottlecz, G.N. Lambrou, O. Strauss,
M. Wiederholt, R. Rosenthal, Effects of unoprostone and endothelin 1 on
L-type channel currents in human trabecular meshwork cells, Ophthalmic
Res. 37 (2005) 293–300.
[6] M. Shimura, K. Yasuda, T. Nakazawa, K. Kashiwagi, The effect of
unoprostone isopropyl on Ca2+ release-activated Ca2+ currents in cultured
monkey trabecular meshwork cells and ciliary muscle cells, J. Ocular
Pharmacol. Ther. 22 (2006) 219–226.
[7] C. Linden, Therapeutic potential of prostaglandin analogues in glaucoma,
Expert Opin. Investig. Drugs 10 (2001) 679–694.
[8] W.C. Stewart, A.E. Kolker, E.D. Sharpe, D.G. Day, K.T. Holmes, J.N.
Leech, N. Johnson, J.B. Cantrell, Factors associated with long-term
progression or stability in primary open-angle glaucoma, Am. J.
Ophthalmol. 130 (2000) 274–279.
[9] G. Tezel, K.D. Siegmund, K. Trinkaus, M.B. Wax, M.A. Kass, A.E.
Kolker, Clinical factors associated with progression of glaucomatous optic
disc damage in treated patients, Arch. Ophthalmol. 119 (2001) 813–818.
[10] J. Flammer, I.O. Haefliger, S. Orgul, T. Resink, Vascular dysregulation: a
principal risk factor for glaucomatous damage? J. Glaucoma 8 (1999)
212–219.
[11] V. Marcheselli, M. DeCoster, Z. Cambell, Neuroprotection by unopros-
tone, but not by latanoprost against glutamate-stimulated Ca2+ influx and
cell death in retinal ganglion cells, Invest. Ophthalmol. Vis. Sci. 42 (2001)
S750.
[12] I. Ogawa, K. Imai, Comparison of visual fields in eyes with normal-tension
glaucoma during 4-year periods of treatment with unoprostone followed by
latanoprost, Folia Ophthalmol. Jpn. 55 (2004) 740–746.
[13] I. Ogawa, K. Imai, Long-term effects on visual fields of unoprostone for
normal-tension glaucoma, Folia Ophthalmol. Jpn. 54 (2003) 571–577.
[14] K. Takeuchi, I. Ohguro, H. Ohguro, M. Nakazawa, Neuroprotective effects
of anti-glaucoma eye drops studied by frequency doubling technology,
Ganka 47 (2005) 889–894.
[15] T. Ishida, Y. Yamada, T. Katayama, A. Koshibu, I. Yamashita, Topical
monotherapy for normal tension glaucoma, Ganka 47 (2005) 1107–1112.
[16] N. Iida, Y. Yamazaki, L. Ito, T. Omata, T. Yajima, A. Takei, T. Hamanaka,
The effect of isopropyl unoprostone on visual field loss in patients with
primary open angle glaucoma, Jpn. Rev. Clin. Ophthalmol. 99 (2005)
707–709.
[17] H. Mukuno, M. Nakamura, A. Kanamori, A. Nagai, A. Negi, G. Seigel,
Unoprostone isopropyl rescues retinal progenitor cells from apoptosis in
vitro, Curr. Eye Res. 29 (2004) 457–464.
[18] K. Hayami, K. Unoki, Photoreceptor protection against constant light-
induced damage by isopropyl unoprostone, a prostaglandin F(2alpha)
metabolite-related compound, Ophthalmic Res. 33 (2001) 203–209.
[19] B. Khodorov, Glutamate-induced deregulation of Ca2+ homeostasis and
mitochondrial dysfunction in mammalian central neurons, Prog. Biophys.
Mol. Biol. 86 (2004) 279–351.
[20] C. Chinopoulos, A.A. Gerencser, J. Doczi, G. Fiskum, V. Adam-Vizi,
Inhibition of glutamate-induced delayed Ca2+ deregulation by 2-APB and
La3+ in cultured cortical neurons, J. Neurochem. 91 (2004) 471–483.
[21] J.M. Simard, Y. Song, K. Tewari, S. Dunn, K. Werrbach-Perez, J.R. Perez-Polo, H.M. Eisenberg, Ionic channel currents in cultured neurons from
human cortex, J. Neurosci. Res. 34 (1993) 170–178.
[22] V.K. Gribkoff, J.T. Lum-Ragan, C.G. Boissard, D.J. Post-Munson,
N.A. Meanwell, J.E. Starrett Jr., E.S. Kozlowski, J.L. Romine,
J.T. Trojnacki, M.C. Mckay, J. Zhong, S.I. Dworetzky, Effects of channel
modulators on cloned large-conductance calcium-activated potassium
channels, Mol. Pharmacol. 50 (1996) 206–217.
[23] V.K. Gribkoff, J.E. Starrett Jr., S.I. Dworetzky, P. Hewawasam,
C.G. Boissard, D.A. Cook, S.W. Frantz, K. Heman, J.R. Hibbard,
K. Huston, G. Johnson, B.S. Krishnan, G.G Kinney, L.A. Lombardo,
N.A. Meanwell, P.B. Molinoff, R.A. Myers, S.L. Moon, A. Ortiz, L. Pajor,
R.L. Pieschl, D.J. Post-Munson, L.J. Signor, N. Srinivas, M.T. Taber,
G. Thalody, J.T. Trojnacki, H. Wiener, K. Yeleswaram, S.W. Yeola,
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K
potassium channels, Nat. Med. 7 (2001) 471–477.
[24] B.S. Jensen, BMS-204352: a potassium channel opener developed for the
treatment of stroke, CNS Drug Rev. 8 (2002) 353–360.
[25] K.W. Hong, K.Y. Kim, H.K. Shin, J.H. Lee, J.M. Choi, Y.G. Kwak, C.D.
Kim, W.S. Lee, B.Y. Rhim, Cilostazol prevents tumor necrosis factor-
alpha-induced cell death by suppression of phosphatase and tensin
homolog deleted from chromosome 10 phosphorylation and activation
of Akt/cyclic AMP response element-binding protein phosphorylation,
J. Pharmacol. Exp. Ther. 306 (2003) 1182–1190.
[26] C.R. Kelly, G.W. Williams, N.A. Sharif, Real-time intracellular Ca2+
mobilization by travoprost acid, bimatoprost, unoprostone, and other
analogs via endogenous mouse, rat, and cloned human FP prostaglandin
receptors, J. Pharmacol. Exp. Ther. 304 (2003) 238–245.
[27] N.A. Sharif, J.Y. Crider, S. Husain, I. Kaddour-Djebbar, H.R. Ansari, A.A.
Abdel-Latif, Human ciliary muscle cell responses to FP-class prostaglan-
din analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization
and MAP kinase activation, J. Ocular Pharmacol. Ther. 19 (2003)
437–455.
[28] N.A. Sharif, C.R. Kelly, J.Y. Crider, G.W. Williams, S.X. Xu, Ocular
hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding
affinities and selectivities, and agonist potencies at FP and other PG
receptors in cultured cells, J. Ocular Pharmacol. Ther. 19 (2003) 501–515.
[29] N.A. Sharif, C.R. Kelly, J.Y. Crider, Human trabecular meshwork cell
responses induced by bimatoprost, travoprost, unoprostone, and other FP
prostaglandin receptor agonist analogues, Invest. Ophthalmol. Vis. Sci. 44
(2003) 715–721.
[30] K. Kashiwagi, Y. Iizuka, S. Tsukahara, Metabolites of isopropyl
unoprostone as potential ophthalmic solutions to reduce intraocular
pressure in pigmented rabbits, Jpn. J. Pharmacol. 81 (1999) 56–62.
[31] P. Bhattacherjee, C.A. Paterson, C. Percicot, Studies on receptor binding
and signal transduction pathways of unoprostone isopropyl, J. Ocular
Pharmacol. Ther. 17 (2001) 433–441.
[32] T. Frieling, C. Rupprecht, G. Dobreva, D. Haussinger, M. Schemann,
Effects of prostaglandin F2 alpha (PGF2 alpha) and prostaglandin I2
(PGI2) on nerve-mediated secretion in guinea-pig colon, Pflugers Arch.
431 (1995) 212–220.
[33] A.D. De Roos, E.J. Van Zoelen, A.P. Theuvenet, Membrane depolarization
in NRK fibroblasts by bradykinin is mediated by a calcium-dependent Cl−
conductance, J. Cell. Physiol. 170 (1997) 166–173.
[34] S. Frings, D. Reuter, S.J. Kleene, Neuronal Ca2+ -activated Cl− channels:
homing in on an elusive channel species, Prog. Neurobiol. 60 (2000)
247–289.
[35] A.D. Gruber, K.D. Schreur, H.L. Ji, C.M. Fuller, B.U. Pauli, Molecular
cloning and transmembrane structure of hCLCA2 from human lung,
trachea, and mammary gland, Am. J. Physiol. 276 (1999) C1261–C1270.
[36] J. Cuppoletti, D.H. Malinowska, K.P. Tewari, Q.J. Li, A.M. Sherry, M.L.
Patchen, R. Ueno, SPI-0211 activates T84 cell Cl− transport and
recombinant human ClC-2 Cl− currents, Am. J. Physiol., Cell Physiol.
287 (2004) C1173–C1183.
[37] E.W. Newell, L.C. Schlichter, Integration of K+ and Cl− currents regulate
steady-state and dynamic membrane potentials in cultured rat microglia,
J. Physiol. 567 (2005) 869–890.
[38] K. Anwer, C. Oberti, G.J. Perez, N. Perez-Reyes, J.K. McDougall, M.
Monga, B.M. Sanborn, E. Stefani, L. Toro, Calcium-activated K+ channels
1092 J. Cuppoletti et al. / Biochimica et Biophysica Acta 1768 (2007) 1083–1092as modulators of human myometrial contractile activity, Am. J. Physiol.
265 (1993) C976–C985.
[39] D.E. Epps, M.L. Wolfe, V. Groppi, Characterization of the steady-state and
dynamic fluorescence properties of the potential-sensitive dye bis-(1,3-
dibutylbarbituric acid)trimethine oxonol (DiBAC4(3)) in model systems
and cells, Chem. Phys. Lipids 69 (1994) 137–150.
[40] A. Yamada, N. Gaja, S. Ohya, K. Muraki, H. Narita, T. Ohwada,
Y. Imaizumi, Usefulness and limitation of DiBAC4(3), a voltage-sensitive
fluorescent dye, for the measurement of membrane potentials regulated by
recombinant large conductance Ca2+ -activated K+ channels in HEK293
cells, Jpn. J. Pharmacol. 86 (2001) 342–350.
[41] G. Grynkiewicz, M. Poenie, R.Y. Tsien, A new generation of Ca2+
indicators with greatly improved fluorescence properties, J. Biol. Chem.
260 (1985) 3440–3450.
[42] A.C. Rego, M.S. Santos, C.R. Oliveira, Oxidative stress, hypoxia, and
ischemia-like conditions increase the release of endogenous amino acids
by distinct mechanisms in cultured retinal cells, J. Neurochem. 66 (1996)
2506–2516.
[43] H. Portzehl, P.C. Caldwell, J.C. Ruegg, The dependence of contraction and
relaxation of muscle fibres from the crab Maia 8quinado on the internal
concentration of free calcium ions, Biochim. Biophys. Acta 79 (1964)
581–591.[44] F. Michelangeli, M.C. Ruiz, E. Fernandez, A. Ciarrocchi, Role of Ca2+ in
H+ transport by rabbit gastric glands studied with A23187 and BAPTA, an
incorporated Ca2+ chelator, Biochim. Biophys. Acta 983 (1989) 82–90.
[45] R.K. Duncan, Tamoxifen alters gating of the BK alpha subunit and
mediates enhanced interactions with the avian beta subunit, Biochem.
Pharmacol. 70 (2005) 47–58.
[46] N.G. Jin, J.K. Kim, D.K. Yang, S.J. Cho, J.M. Kim, E.J. Koh, H.C. Jung,
I. So, K.W. Kim, Fundamental role of ClC-3 in volume-sensitive Cl−
channel function and cell volume regulation in AGS cells, Am. J. Physiol.:
Gasterointest. Liver Physiol. 285 (2003) G938–G948.
[47] B. Sjorquist, J. Stjernschantz, Ocular and systemic pharmacokinetics of
latanoprost in humans, Surv. Ophthalmol. 47 (2002) S6–S12.
[48] N.N. Osborne, G. Chidlow, J.P. Wood, Glutamate excitotoxicity in
glaucoma: truth or fiction? by AJ Lotery, Eye (2006) 1–2.
[49] N.N. Osborne, J. Melena, G. Chidlow, J.P. Wood, A hypothesis to explain
ganglion cell death caused by vascular insults at the optic nerve head:
possible implication for the treatment of glaucoma, Br. J. Ophthalmol. 85
(2001) 1252–1259.
[50] K.Y. Wu, H.Z. Wang, S.J. Hong, Inhibition of endothelin-1 and KCl-
induced increase of [Ca2+]i by antiglaucoma drugs in cultured A7r5
vascular smooth-muscle cells, J. Ocular Pharmacol. Ther. 20 (2004)
201–209.
